Novamind

Mental healthcare company advancing psychedelic-assisted therapies Numinus Wellness Inc. (OTCQX: NUMIF) recently announced its fiscal quarter results for the three and nine months ended May 31, 2022.  The results do not reflect contributions from the acquisition of Novamind, completed after...

Novamind (OTCQB: NVMDF), which is to be acquired by Numinus Wellness (OTCMKTS: NUMIF), recently announced a collaboration with health coaching platform HealCommunity. The collaboration with HealCommunity will help expand the recently announced Groups by Novamind project, by providing remote group...

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. A smattering of small-scale studies provided researchers with encouraging evidence that psilocybin mushrooms could become a leading treatment for depression...

Novamind Inc. (OTCQB: NVMDF), a mental health company specializing in psychedelic medicine, has announced the launch of a new clinic located in downtown Salt Lake City specializing in integrative behavioral health and services for adults with substance use disorders.  The company notes that in...

Novamind Inc. (OTCQB: NVMDF) a mental health company specializing in psychedelic medicine, recently announced a strategic investment and advisory agreement with Bienstar Wellness Corp, an Uruguay-based mental health company, to assist in the expansion of Latin America's first network of...

The healthcare sector is booming and startups are the driving force behind the innovations that will affect the future of life on earth. Running its last day on Thursday, Benzinga’s Healthcare Small Cap Conference provides investors and analysts with conversations and presentations from...

Novamind Strikes Research Deal With Merck Psychedelics company Novamind (PINK: NVMDF) announced a subsidiary has been selected as a research site for a clinical trial of a compound developed by pharma giant Merck (NYSE: MRK). The phase II trial will assess the efficacy and safety of MK-1942,...

In 2020, psychedelics took the world by storm. Over two dozen companies in the sector became publicly listed.  The industry grew closer to federal legalization of the first psychedelic compounds for therapeutic use. With scientific, regulatory and corporate developments becoming...

NeonMind Goes Public Psychedelics biotech company NeonMind debuted on the Canadian Securities Exchange (CSE) Monday under the symbol ‘NEON.’ NeonMind CEO Penny White discussed the highly anticipated — oversubscribed — initial public offering (IPO) on the Jan. 7 edition...

Novamind became the latest psychedelics company to go public through a reverse take-over with Hinterland Metals Inc. The company debuted in the Canadian Securities Exchange on Tuesday under the symbol "NM." In late November, Novamind closed a private placement for CA$10 million ($7.8...

The Psychedelics Sector Might Soon Get Its First ETF Financial services company Horizons ETFs Management filed documents with the Ontario Securities Commission for a psychedelics ETF, which is expected to go live on Jan. 15. The ‘Horizons Psychedelic Stock Index ETF’ would become the...

PSYCHED is now weekly! As the psychedelics industry grows, so does the need for news. For this reason, our column covering the most important developments in medicinal psychedelics is now a weekly feature.  Mydecine To Acquire NeuroPharm Functional fungi and psychedelics company Mydecine...